Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Psychemedics Corp (NASDAQ:PMD)

Delayed Data
As of Feb 27
 +0.93 / +4.44%
Today’s Change
Today|||52-Week Range
Health Services
Services to the Health Industry

Company Description

Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. Its testing methods utilize a technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The firm performs custom-designed enzyme immunoassay on the liquid supernatant, with confirmation testing by mass spectrometry. It provides screening and confirmation by mass spectrometry for cocaine; marijuana; phencyclidine; amphetamines including ecstasy; and opiates such as including heroin, hydrocodone, hydromorphone, oxycodone and codeine. The company was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.

Contact Information

Psychemedics Corp.
125 Nagog Park
Acton Massachusetts 01720
P:(877) 517-2033
Investor Relations:



Other institutional43.24%
Individual stakeholders18.94%
Mutual fund holders10.46%

Top Executives

Raymond C. KubackiChairman, President & Chief Executive Officer
Neil L. LernerTreasurer & Vice President-Finance
Sarah E. AshbyVice President & General Counsel
Michael I. SchafferVice President-Laboratory Operations
James V. DykeVice President-Sales & Marketing